Skip to content
Disclosery

Paradigm Biocapital Advisors LP: EWTX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Paradigm Biocapital Advisors LP on EWTX, newest first. How the timeline and the estimate are built.

Paradigm Biocapital Advisors LP held 10,215,455 EWTX shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 10,215,455 shares
    Change vs previous 13F +2,850,417 shares

    7.77% of the 13F portfolio, value $415,053,937.

    13F-HR 0001855655-26-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 7,365,038 shares
    Change vs previous 13F +823,828 shares

    4.74% of the 13F portfolio, value $231,998,697.

    13F-HR 0001855655-26-000011 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 6,541,210 shares
    Change vs previous 13F +371,079 shares

    4.35% of the 13F portfolio, value $162,320,126.

    13F-HR 0001855655-26-000003 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 6,170,131 shares
    Change vs previous 13F +27,787 shares

    2.96% of the 13F portfolio, value $100,079,525.

    13F-HR 0001855655-25-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 6,142,344 shares
    Change vs previous 13F +1,747,788 shares

    3.44% of the 13F portfolio, value $80,526,130.

    13F-HR 0001855655-25-000010 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 4,394,556 shares
    Change vs previous 13F -99,373 shares

    4.45% of the 13F portfolio, value $96,680,232.

    13F-HR 0001855655-25-000007 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 4,493,929 shares
    Change vs previous 13F +1,704,757 shares

    4.17% of the 13F portfolio, value $119,987,904.

    13F-HR 0001855655-25-000004 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 2,789,172 shares
    Change vs previous 13F not available

    2.61% of the 13F portfolio, value $74,443,001.

    13F-HR 0001855655-24-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).